LI
DGX icon

Leap Investments’s Quest Diagnostics DGX Stock Holding History

Leap Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$205K Buy
+1,800
New +$191K 0.14% 291

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Leap Investments's DGX Position: Q2 2020 in Review

Leap Investments opened a new position in Quest Diagnostics (DGX) in Q2 2020: 1,800 shares worth $205K. The stake represents 0.14% of the portfolio and ranks #291 among its holdings.

748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Leap Investments held 1,800 shares of Quest Diagnostics worth $205K as of Q2 2020.
  • Quest Diagnostics was a new Leap Investments position in Q2 2020.
  • Quest Diagnostics made up 0.14% of Leap Investments's portfolio in Q2 2020, its #291 holding.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.